Canadian ganja dreams go up in smoke
Jamaica’s long delay in promulgating regulations for the commercial export of cannabis has resulted in a Canadian company pulling back on its expansion plans in Jamaica.
The company in question, the Green Organic Dutchman, out of Canada, which has partnered with local cannabis company Epican Medicinal has pulled back on its expansion plans in Jamaica citing market conditions on the island, which have forced it to revise its short- and long-term growth forecasts.
This has caused the company to forgo the expansion of its proposed cultivation activities for export in Jamaica, in order to focus on its Canadian operations. This was disclosed in the company’s March financial statements.
UNABLE TO RECOUP JAMAICAN INVESTMENT
Green Organic Dutchman Chief Financial Officer Sean Bovingdon reportedly told investors during a conference call in March that it was unlikely that the company would be able to recoup, in the short term, roughly C$4 million ($130 million) it had invested in Jamaica. The statement arrived in the context of the work done by the Cannabis Licensing Authority (CLA) to boost the industry post-COVID-19.
The CLA is charged with the responsibility of regulating the legal cannabis industry and through the regulations will be able to grant import and export licences for businesses in the medicinal cannabis industry. The Jamaica Observer understands Green Organic Dutchman is among the foreign companies that have invested in Jamaica’s legal cannabis industry which, while acknowledging the regulatory delays, have declared that the overall uncertainty is a cause for concern.
CONCERN OVER DELAYS IN EXPORT REGULATIONS
Industry players are already raising concerns about the long delay in the regulations being promulgated. The regulations were announced earlier this year and were to have come into effect by April, as part of a targeted support programme for small and medium-sized enterprises in various industries.
However, the draft regulations, which have been back and forth among a number of government entities, have been delayed due to the COVID-19 pandemic, which is now at the centre of national concern. The first-draft regulations for the commercial export of cannabis, having been completed since last August, have been making the rounds among the Ministry of Industry, Commerce, Agriculture and Fisheries, Attorney General’s Department, Chief Parliamentary Counsel, and the CLA.
LONGER WAIT FOR REGULATIONS
Industry officials are not saying how long the wait will be, nor were they willing to commit to a date when the regulations would be promulgated. Audley Shaw, whose Ministry of Industry, Commerce, Agriculture and Fisheries is pushing the regulations, was recently quoted as saying work is still being done on having the regulations completed.
He stated that much of the regulations have been finalised and are “due to be submitted to the Office of the Parliamentary Counsel”. He told Cannabis Wire that the delay was expected, arguing that the COVID-19 pandemic in the Caribbean could set the development of the industry across the islands back by at least a year in some cases.
On promulgation of the regulations, the CLA will have jurisdiction or the statutory authority to grant licences and permits for import/export of inflorescence/flower and extract/resin. This will make Jamaica one of only 10 countries in the world with an export regime.
The CLA through the regulations will be able to grant import and export licences for businesses in the medicinal cannabis industry.
Now you can read the Jamaica Observer ePaper anytime, anywhere. The Jamaica Observer ePaper is available to you at home or at work, and is the same edition as the printed copy available at http://bit.ly/epaperlive